Physician profile
San Tso
NPI 1598876716
$16,945.69
in general payments reported to CMS, 2019-2025
75 companies · $3,242 in 2025
The $3,242 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,096 · 2020: $2,157 · 2021: $1,949 · 2022: $2,286 · 2023: $2,770 · 2024: $2,445 · 2025: $3,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,439 · Entertainment: $17.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,439.41 |
| Entertainment | $17.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,608.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,422.29 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $1,303.83 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $1,281.55 | 2020-2025 | Vraylar, Viberzi, Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,110.96 | 2019-2025 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $982.26 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $925.25 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $676.14 | 2019-2025 | Dificid, Rotateq, Vaxneuvance |
| Otsuka America Pharmaceutical, INC. | $669.56 | 2019-2025 | Rexulti, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $664.78 | 2019-2025 | Spravato |
| Amgen INC. | $592.63 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $467.72 | 2019-2025 | Xifaxan |
| Exact Sciences Corporation | $395.63 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $264.79 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $252.76 | 2021-2025 |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $246.69 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $231.95 | 2019-2025 | Hetlioz, Fanapt |
| Astellas Pharma US INC | $209.71 | 2019-2025 | Veozah |
| Allergan, INC. | $178.61 | 2020 | |
| Lundbeck LLC | $175.66 | 2022-2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company Ltd. | $170.61 | 2022 | |
| Hologic Sales and Service, LLC | $168.53 | 2020-2025 | Aptima |
| Sunovion Pharmaceuticals INC. | $168.32 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $154.29 | 2020-2023 | |
| Axsome Therapeutics, INC. | $148.00 | 2024-2025 | Auvelity |
| Biohaven Pharmaceuticals, INC. | $140.63 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $138.06 | 2022-2025 | Zoryve |
| Aimmune Therapeutics, INC. | $124.84 | 2025 | Zenpep |
| Teva Pharmaceuticals USA, INC. | $117.76 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $114.59 | 2024 | Voquezna |
| Cranial Technologies, INC | $112.54 | 2022-2025 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $103.99 | 2019-2023 | Trintellix |
| Mylan Specialty L.P. | $100.11 | 2019-2024 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $98.63 | 2019-2022 | |
| Eisai INC. | $84.57 | 2020-2025 | |
| Amarin Pharma, INC. | $83.06 | 2019-2020 | |
| Abbott Laboratories | $82.49 | 2021-2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $78.31 | 2022-2025 | Caplyta |
| Baxter Healthcare | $70.45 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Idorsia Pharmaceuticals US INC | $68.47 | 2023-2024 | Quviviq |
| Ironwood Pharmaceuticals, INC | $67.66 | 2019-2024 | Linzess |
| Corcept Therapeutics | $65.85 | 2024 | Korlym |
| Alexion Pharmaceuticals, INC. | $55.99 | 2024-2025 | Strensiq |
| Mannkind Corporation | $54.31 | 2019 | |
| Electromed, INC. | $53.93 | 2019-2022 | |
| Sanofi Pasteur INC. | $53.23 | 2019-2020 | |
| Philips North America LLC | $47.80 | 2020-2024 | (5050) Extended Holter |
| Advanced Respiratory, INC | $46.29 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $39.70 | 2023 | Gemtesa |
| Mayne Pharma Commercial LLC | $37.91 | 2023-2025 | |
| Viatris Specialty LLC | $35.16 | 2025 | Yupelri |
| Boston Scientific Corporation | $29.26 | 2025 | General - Pain Management |
| Kyowa Kirin, INC. | $25.68 | 2023 | Crysvita |
| Nabriva Therapeutics, Plc | $23.63 | 2021 | |
| Genzyme Corporation | $22.05 | 2025 | |
| Arbor Pharmaceuticals, INC. | $19.31 | 2021 | |
| Seqirus USA INC | $17.89 | 2019 | |
| Biogen, INC. | $17.77 | 2019 | |
| Optos, INC. | $17.28 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Almatica Pharma LLC | $17.18 | 2023 | Loreev Xr |
| Assertio Therapeutics, INC. | $16.84 | 2019 | |
| Verona Pharma, INC. | $16.84 | 2025 | Ohtuvayre |
| Evofem Biosciences, INC. | $16.38 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.76 | 2023 | Belbuca |
| Forte Bio-Pharma LLC | $15.73 | 2020 | |
| Covis Pharma Gmbh | $14.38 | 2022 | |
| Nevro Corp. | $14.17 | 2023 | Senza |
| Currax Pharmaceuticals LLC | $13.71 | 2023 | Contrave |
| Xeris Pharmaceuticals, INC. | $13.14 | 2022 | |
| Lupin INC. | $12.64 | 2019 | |
| Hikma Pharmaceuticals USA | $12.62 | 2021 | |
| Eyevance Pharmaceuticals LLC | $12.62 | 2021 | |
| Therapeuticsmd, INC. | $11.44 | 2019 | |
| Circassia INC. | $11.14 | 2019 | |
| Horizon Therapeutics Plc | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw San Tso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.